Abstract
Being the most common group of congenital malformations, congenital heart defects have often been investigated to rule out teratogenic effects by medicinal drugs and chemicals. Yet, the use of rigorous epidemiological methods has rejected such claims in many cases. We critically evaluate drugs believed to be associated with an increased risk of causing congenital heart defects, highlighting the debate and the practical implications of such associations.
| Original language | English |
|---|---|
| Pages (from-to) | 20-24 |
| Number of pages | 5 |
| Journal | Journal of Cardiovascular Pharmacology |
| Volume | 58 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Jan 2011 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cardiac birth defects
- congenital malformations
- drugs safety
- pregnancy
ASJC Scopus subject areas
- Pharmacology
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Drug exposure in pregnancy and heart defects'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver